Pressroom

Featured News​

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced that it acted as the exclusive placement agent in connection with a $2.5 million private placement for iSpecimen Inc.

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced it served as exclusive M&A advisor and placement agent in connection with the successful closing of Shuttle Pharmaceuticals Holdings, Inc.’s (NASDAQ: SHPH) acquisition of United Dogecoin Inc.

E.F. Hutton & Co. Serves as Exclusive Placement Agent on VCI Global’s $5 Million Institutional Registered Direct Offering

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it acted as the exclusive placement agent in connection with a $5 million institutional registered direct offering by VCI Global Limited (NASDAQ: VCIG) (“VCI Global”)

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Gaithersburg, Maryland--(Newsfile Corp. - March 6, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular discovery and early-stage drug development

recent transactions

Contact Us

Your needs are important to us. Take a moment to complete the form, and we'll make sure to contact you as soon as possible.

    Multi-Level Sidebar